Annual Drug Patent Expirations for ZAVZPRET
Zavzpret is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug.
This drug has sixty-four patent family members in thirty-five countries.
The generic ingredient in ZAVZPRET is zavegepant hydrochloride. Two suppliers are listed for this compound. Additional details are available on the zavegepant hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com